Measurement of liver stiffness as a non-invasive method for diagnosis of non-alcoholic fatty liver disease

Hepatology Research

Volumn 45, Issue 2, 2015, Pages 142-151

  Yoshioka, Kentaro ^a   Hashimoto, Senju ^a   Kawabe, Naoto ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Acoustic radiation force impulse; Magnetic resonance elastography; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Real time tissue elastography; Transient elastography

Indexed keywords

BIOCHEMICAL MARKER;

ACOUSTIC RADIATION FORCE IMPULSE IMAGING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ELASTOGRAPH; ELASTOGRAPHY; HUMAN; INFLAMMATION; LIVER CELL; LIVER FIBROSIS; LIVER STIFFNESS; MAGNETIC RESONANCE ELASTOGRAPHY; NON INVASIVE MEASUREMENT; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME TISSUE ELASTOGRAPHY; REAL TIME ULTRASOUND SCANNER; REVIEW; RIGIDITY; SENSITIVITY AND SPECIFICITY;

EID: 84921600056     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12388     Document Type: Review

References (40)

1. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-285.
2. Chalasani N, Younossi Z, Lavine JE etal. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol 2012; 107: 811-826.
3. Ratziu V, Charlotte F, Heurtier A etal. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898-1906.
4. Kim SU, Kim JK, Park YN, Han KH. Discordance between liver biopsy and Fibroscan(R) in assessing liver fibrosis in chronic hepatitis b: risk factors and influence of necroinflammation. PLoS ONE 2012; 7: e32233.
5. Foucher J, Castera L, Bernard PH etal. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006; 18: 411-412.
6. Bota S, Sporea I, Sirli R etal. Factors associated with the impossibility to obtain reliable liver stiffness measurements by means of Acoustic Radiation Force Impulse (ARFI) elastography - analysis of a cohort of 1, 031 subjects. Eur J Radiol 2014; 83: 268-272.
7. Nitta Y, Kawabe N, Hashimoto S etal. Liver stiffness measured by transient elastography correlates with fibrosis area in liver biopsy in patients with chronic hepatitis C. Hepatol Res 2009; 39: 675-684.
8. Nishikawa T, Hashimoto S, Kawabe N etal. Factors correlating with acoustic radiation force impulse elastography in chronic hepatitis C. World J Gastroenterol 2014; 20: 1289-1297.
9. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419.
10. Kawaguchi T, Sumida Y, Umemura A etal. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS ONE 2012; 7: e38322.
11. Kleiner DE, Brunt EM, Van Natta M etal. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
12. Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 2011; 53: 810-820.
13. Sandrin L, Fourquet B, Hasquenoph JM etal. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-1713.
14. Yoneda M, Yoneda M, Mawatari H etal. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008; 40: 371-378.
15. Nobili V, Vizzutti F, Arena U etal. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 2008; 48: 442-448.
16. Wong VW, Vergniol J, Wong GL etal. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010; 51: 454-462.
17. Lupsor M, Badea R, Stefanescu H etal. Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis. J Gastrointestin Liver Dis 2010; 19: 53-60.
18. Petta S, Di Marco V, Camma C, Butera G, Cabibi D, Craxi A. Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Aliment Pharmacol Ther 2011; 33: 1350-1360.
19. Mahadeva S, Mahfudz AS, Vijayanathan A, Goh KL, Kulenthran A, Cheah PL. Performance of transient elastography (TE) and factors associated with discordance in non-alcoholic fatty liver disease. J Dig Dis 2013; 14: 604-610.
20. Wong VW, Vergniol J, Wong GL etal. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 2012; 107: 1862-1871.
21. Myers RP, Pomier-Layrargues G, Kirsch R etal. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 2012; 55: 199-208.
22. de Ledinghen V, Vergniol J, Foucher J, El-Hajbi F, Merrouche W, Rigalleau V. Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int 2010; 30: 1043-1048.
23. Gaia S, Carenzi S, Barilli AL etal. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 2011; 54: 64-71.
24. Nguyen-Khac E, Capron D, Braillon A, Dupas JL. The non-invasive diagnosis of cirrhosis using the Fibroscan must be performed with cause-specific stiffness cut-offs. Gut 2008; 57: 1630; author reply 1630-1.
25. Sasso M, Beaugrand M, de Ledinghen V etal. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 2010; 36: 1825-1835.
26. Friedrich-Rust M, Wunder K, Kriener S etal. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology 2009; 252: 595-604.
27. Saito M. Virtual palpitation. Jpn J Med Ultrasound Technol 2008; 33: 659-665.
28. Yoneda M, Suzuki K, Kato S etal. Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. Radiology 2010; 256: 640-647.
29. Palmeri ML, Wang MH, Rouze NC etal. Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. J Hepatol 2011; 55: 666-672.
30. Guzman-Aroca F, Frutos-Bernal MD, Bas A etal. Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging. Eur Radiol 2012; 22: 2525-2532.
31. Fierbinteanu Braticevici C, Sporea I, Panaitescu E, Tribus L. Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease. Ultrasound Med Biol 2013; 39: 1942-1950.
32. Friedrich-Rust M, Romen D, Vermehren J etal. Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. Eur J Radiol 2012; 81: e325-331.
33. Friedrich-Rust M, Ong MF, Herrmann E etal. Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis. AJR Am J Roentgenol 2007; 188: 758-764.
34. Tomeno W, Yoneda M, Imajo K etal. Evaluation of the Liver Fibrosis Index calculated by using real-time tissue elastography for the non-invasive assessment of liver fibrosis in chronic liver diseases. Hepatol Res 2013; 43: 735-742.
35. Orlacchio A, Bolacchi F, Antonicoli M etal. Liver elasticity in NASH patients evaluated with real-time elastography (RTE). Ultrasound Med Biol 2012; 38: 537-544.
36. Ochi H, Hirooka M, Koizumi Y etal. Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases. Hepatology 2012; 56: 1271-1278.
37. Yin M, Talwalkar JA, Glaser KJ etal. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 2007; 5: 1207-1213 e2.
38. Levenson H, Greensite F, Hoefs J etal. Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy. AJR Am J Roentgenol 1991; 156: 307-312.
39. Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 2011; 259: 749-756.
40. Kim D, Kim WR, Talwalkar JA, Kim HJ, Ehman RL. Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. Radiology 2013; 268: 411-419.